000124298 001__ 124298
000124298 005__ 20240303002404.0
000124298 0247_ $$2doi$$a10.1093/neuonc/nox039
000124298 0247_ $$2pmid$$apmid:28379448
000124298 0247_ $$2pmc$$apmc:PMC5464452
000124298 0247_ $$2ISSN$$a1522-8517
000124298 0247_ $$2ISSN$$a1523-5866
000124298 0247_ $$2altmetric$$aaltmetric:35200733
000124298 037__ $$aDKFZ-2017-01194
000124298 041__ $$aeng
000124298 082__ $$a610
000124298 1001_ $$aFouladi, Maryam$$b0
000124298 245__ $$aMEK and RAF inhibitors: time for a paradigm shift in the treatment of pediatric low-grade gliomas?
000124298 260__ $$aOxford$$bOxford Univ. Press$$c2017
000124298 3367_ $$2DRIVER$$aarticle
000124298 3367_ $$2DataCite$$aOutput Types/Journal article
000124298 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1510231988_16003
000124298 3367_ $$2BibTeX$$aARTICLE
000124298 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000124298 3367_ $$00$$2EndNote$$aJournal Article
000124298 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000124298 588__ $$aDataset connected to CrossRef, PubMed,
000124298 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan$$b1$$eLast author$$udkfz
000124298 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/nox039$$gVol. 19, no. 6, p. 741 - 743$$n6$$p741 - 743$$tNeuro-Oncology$$v19$$x1523-5866$$y2017
000124298 909CO $$ooai:inrepo02.dkfz.de:124298$$pVDB
000124298 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000124298 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000124298 9141_ $$y2017
000124298 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000124298 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000124298 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2015
000124298 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000124298 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000124298 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000124298 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000124298 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000124298 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000124298 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000124298 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEURO-ONCOLOGY : 2015
000124298 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x0
000124298 980__ $$ajournal
000124298 980__ $$aVDB
000124298 980__ $$aI:(DE-He78)B062-20160331
000124298 980__ $$aUNRESTRICTED